Skip to main content
SpringerLink
Log in

Antiestrogen action and growth factor regulation

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The basis of the anti-proliferative action of antiestrogens is generally considered to be their ability to inhibit estrogen induced growth pathways by competitively inhibiting the binding of estrogen to the estrogen receptor. Recent data suggest that this may not be the entire story. Moreover, the cascade of events responsible for inhibition of mitogenesis after an initial interaction with the estrogen receptor is poorly understood. Multiple growth factor pathways operate in both normal and neoplastic estrogen/antiestrogen target tissues. While it is unlikely that any single pathway is pivotal, interactions of estrogen and/or antiestrogens with some of these pathways have been implicated in their proliferative effects. The exact molecular mechanisms remain unclear but autocrine, paracrine/juxtacrine, intracrine, and endocrine mediators or various combinations of them are likely to be involvedin vivo. Super-imposed on this is the possibility that ‘cross-talk’ between intracellular signaling pathways may also be involved. Elucidation of such molecular mechanisms will be important with respect to design of novel antiestrogenic/antimitogenic drugs and alternative treatment strategies for both breast and uterine cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lippman ME, Dickson RB: Mechanisms of growth control in normal and malignant breast epithelium. Rec Prog Horm Res 45: 383–440, 1989

    Google Scholar 

  2. Imagawa W, Bandyopadhyay GK, Nandi S: Regulation of mammary epithelial cell growth in mice and rats. Endocr Rev 11: 494–523, 1990

    Google Scholar 

  3. Malet C, Gompel A, Spritzer P, Bricout N, Yaneva H, Mowszowicz I, Kuttenn F, Mauvais-Jarvis P: Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture. Cancer Res 48: 7193–7199, 1988

    Google Scholar 

  4. Gabelman BM, Emerman JT: Effects of estrogen, epidermal growth factor and transforming growth factor-α on the growth of human breast epithelial calls in primary culture. Exp Cell Res 201:113–118, 1992

    Google Scholar 

  5. Bronzert DA, Bates SE, Sheridan JP, Lindsey R, Valverius EM, Stampfer MR, Lippman ME, Dickson RB: Transforming growth factor-β induces platelet-derived growth factor (PDGF) messenger RNA and PDGF secretion while inhibiting growth in normal human mammary epithelial cells. Mol Endocrin 4: 981–989, 1990

    Google Scholar 

  6. Bates SE, Valverius EM, Ennis BW, Bronzert DA, Sheridan JP, Stampfer M, Mendelsohn J, Lippman ME, Dickson RB: Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinol 126: 596–607, 1990

    Google Scholar 

  7. Valverius EM, Walker-Jones D, Bates SE, Stampfer MR, Clark R, McCormick F, Salomon DS, Dickson RB, Lippman ME: Production and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. Cancer Res 49: 6269–6274, 1989

    Google Scholar 

  8. Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME: Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 51: 4978–4985, 1991

    Google Scholar 

  9. Yee D, Paik S, Lebovic G, Marcus R, Favoni R, Cullen K, Lippman ME, Rosen N: Analysis of IGF-I gene expression in malignancy - evidence for a paracrine role in human breast cancer. Mol Endocrinol 3: 509–517, 1989

    Google Scholar 

  10. Murphy LC, Dotzlaw H, Wong MSJ, Miller T, Mrockowski B, Gong Y, Murphy LJ: Epidermal growth factor: receptor and ligand expression in human breast cancer. Seminars in Cancer Biology 1: 305–315, 1990

    Google Scholar 

  11. Gomm JJ, Smith J, Ryall GK, Baillie R, Turnbull L, Coombes RC: Localization of basic fibroblast growth factor and transforming growth factor β1 in human mammary gland. Cancer Res 51: 4685–4692, 1991

    Google Scholar 

  12. Hammond SL, Ham RG, Stampfer MR: Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci USA 81: 5435–5439, 1984

    Google Scholar 

  13. Zajchowski D, Band V, Pauzie N, Tager A, Stampfer MR, Sager R: Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells. Cancer Res 48: 7041–7047, 1988

    Google Scholar 

  14. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC: Isolation and characterization of a spontaneous immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075–6086, 1990

    Google Scholar 

  15. McGrath CM: Augmentation of the response of normal mammary cells to estradiol by mammary stroma. Cancer Res 43: 1355–1360, 1983

    Google Scholar 

  16. Brown CF, Teng CT, Pentecost BT, DiAugustine RP: Epidermal growth factor precursor in mouse lactating mammary gland alveolar cells. Mol Endocrinol 3:1077–1083, 1989

    Google Scholar 

  17. Peltz SW, Katzenellenbogen BS, Kneifel MA, Mangel WF: Plasminogen activators in tissues of the immature and estrogen-stimulated rat uterus and in uterine luminal fluid: characterization and properties. Endocrinol 112: 890–897, 1983

    Google Scholar 

  18. Casslen B, Andersson A, Nilsson IN, Astedt B: Hormonal regulation of the release of plasminogen activators and of a specific activator/inhibitor from endometrial tissue in culture. Proc Soc Exp Biol Med 182: 419, 1986

    Google Scholar 

  19. Leygur E, Louis-Sylvestre C, Gol R, Malet C, Baudot N, Cumins C, Mowszowicz I, Kuttenn F, Mauvais-Jarvis P: Estrogen regulation of c-myc in normal human breast epithelial (HBE) cells in culture. Proc 75th Annual Meeting Endocrine Soc, Las Vegas, Abstr No. 1914, 1993

  20. Rozengurt E, Sinnett-Smith J, Taylor-Papadimitriou J: Production of PDGF-like growth factor activity by breast cancer cell lines. Int J Cancer 36: 247–252, 1985

    Google Scholar 

  21. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N: Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48: 6691–6696, 1988

    Google Scholar 

  22. Flamm SL, Wellstein A, Lupu R, Kern F, Lippman ME, Gelmann EP: Expression of fibroblast growth factor peptides in normal and malignant human mammary epithelial cells. Proc Am Assoc Cancer Res 30: 71, 1989

    Google Scholar 

  23. Yee D, Rosen N, Favoni RE, Cullen KJ: The insulin-like growth factors, their receptors and their binding proteins in human breast cancer. Cancer Treat Res 53: 93–104, 1991

    Google Scholar 

  24. Imai Y, Leung CKH, Friesen HG, Shiu RPC: Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long term tissue culture. Cancer Res 42: 4394–4398, 1982

    Google Scholar 

  25. Slamon D, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of HER-2/neu oncogene. Science 235: 177–182, 1987

    Google Scholar 

  26. Kraus MH, Fedi P, Starks V, Muraro R, Aaronson SA: Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells. Proc Natl Acad Sci 90: 2900–2904, 1993

    Google Scholar 

  27. Koga M, Sutherland RL: Epidermal growth factor partially reverses inhibitory effects of antiestrogens on T-47D human breast cancer cell growth. Biochem Biophys Res Commun 146: 739–745, 1987

    Google Scholar 

  28. Gong Y, Ballejo G, Murphy LC, Murphy LJ: Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Cancer Res 52: 1704–1709, 1992

    Google Scholar 

  29. Arteaga CL, Osborne CK: Growth factors as mediators of estrogen/antiestrogen action in human breast cancer cells. In: Lippman ME, Dickson RB (eds) Regulatory Mechanisms in Breast Cancer. Kluwer Academic Publishers, Boston, 1991, pp 289–304

    Google Scholar 

  30. Eppstein DA, Marsh YV, Schryver BB, Bertics PJ: Inhibition of EGF/TGF-α stimulated cell growth by a synthetic peptide. J Cell Physiol 141: 420–430, 1989

    Google Scholar 

  31. Clarke R, Brunner N, Katz D, Glanz P, Dickson RB, Lippman ME, Kern FG: The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cellsin vitro andin vivo. Mol Endocrinol 3: 372–380, 1989

    Google Scholar 

  32. Keating MT, Williams LT: Autocrine stimulation of intracellular PDGF receptors in v-sis transformed cells. Science 239: 914–916, 1988

    Google Scholar 

  33. Reddy KB, Yee D, Coffey RJ, Osborne CK: Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor-alpha expression. Proc Am Assoc Cancer Res 34: 236, abstr 1406, 1993

    Google Scholar 

  34. Murphy LC, Murphy LJ, Dubik D, Bell GI, Shiu RPC: Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. Cancer Res 48: 4555–4560, 1988

    Google Scholar 

  35. Berthois Y, Dong XF, Martin PM: Regulation of epidermal growth factor receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7. Biochem Biophys Res Commun 159: 126–131, 1989

    Google Scholar 

  36. Sainsbury JRC, Needham GK, Malcolm A, Farndon JR, Harris AL: Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet i: 1398, 1987

    Google Scholar 

  37. Valverius EM, Velu T, Shankar V, Ciardiello F, Kim N, Salomon DS: Over-expression of the epidermal growth factor receptor in human breast cancer cells fails to induce an estrogen-independent phenotype. Int J Cancer 46: 712–718, 1990

    Google Scholar 

  38. van Agthoven T, van Agthoven TL, Portengen H, Foekens JA, Dorssers LC: Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res 52: 5082–5088, 1992

    Google Scholar 

  39. Colletti RB, Roberts JD, Devlin JT, Copeland KC: Effect of tamoxifen on plasma insulin-like growth factor-I in patients with breast cancer. Cancer Res 49: 1881–1884, 1989

    Google Scholar 

  40. Cullen KJ, Lippman ME, Chow D, Hill S, Rosen N, Zwiebel JA: Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol Endocrinol 6: 91–99, 1992

    Google Scholar 

  41. Osborne CK, Coronado EB, Kitten LJ, Arteaga CL, Fuqua SAW, Ramasharma K, Marshall M, Li CH: Insulin-like growth factor II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 3: 1701–1709, 1989

    Google Scholar 

  42. Clemmons DR, Camacho-Hubner C, Coronado EB, Osborne CK: Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology 127: 2679–2686, 1990

    Google Scholar 

  43. Sheikh MS, Shao ZM, Clemmons DR, LeRoith D, Roberts CT Jr, Fontana JA: Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells. Biochem Biophys Res Commun 183: 1003–1010, 1992

    Google Scholar 

  44. Lonning PE, Hall K, Aalvaag A, Lien EA: Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein 1 in breast cancer patients. Cancer Res 52: 4719–4723, 1992

    Google Scholar 

  45. Coutts A, Murphy LJ, Murphy LC: Regulation of IGF-binding protein by progestins and antiestrogens in T-47D human breast cancer cells. Proc Am Assoc Cancer Res 34: 552, 1993

    Google Scholar 

  46. Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK: Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48: 3898–3904, 1988

    Google Scholar 

  47. Arrick BA, Korc M, Derynck R: Differential regulation of the expression of three transforming growth factor β species in human breast cancer cell lines by estradiol. Cancer Res 50: 299–303, 1990

    Google Scholar 

  48. Dickson RB, Kasid A, Huff KK, Bates SE, Knabbe C, Bronzert D, Gelman EP, Lippman ME: Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β-estradiol or v-Ha-ras oncogene. Proc Natl Acad Sci USA 84: 837–841, 1987

    Google Scholar 

  49. Daly RJ, Darbre PD: Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47D human breast cancer cells. Cancer Res: 50: 5868–5875, 1990

    Google Scholar 

  50. Arteaga CL, Carty-Dugger T, Moses HL, Hurd SD, Pietenpol JA: Transforming growth factor β1 can induce estrogenindependent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Diff 4: 193–201, 1993

    Google Scholar 

  51. Kasid A, Lippman ME, Papageorge AG, Lowy DR, Gelman EP: Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity. Science 228: 725–728, 1985

    Google Scholar 

  52. Robinson SP, Jordan VC: The paracrine stimulation of MCF-7 cells by MDA-MB-231 cells: possible role in antiestrogen failure. Eur J Cancer Clin Oncol 25: 493–497, 1989

    Google Scholar 

  53. Vignon F, Bouton MM, Rochefort H: Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146: 1502–1508, 1987

    Google Scholar 

  54. Wakeling A, Newboult E, Peters SW: Effects of antiestrogens on the proliferation of MCF-7 human breast cancer cells. J Mol Endocrinol 2: 225–234, 1989

    Google Scholar 

  55. Freiss G, Prebois C, Rochefort H, Vignon F: Anti-steroidal and anti-growth factor activities of antiestrogens. J Steroid Biochem Mol Biol 37: 777–781, 1990

    Google Scholar 

  56. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS: Coupling of dual signalling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci (USA) 89: 4658–4662, 1992

    Google Scholar 

  57. Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A, Osborne CK: Inhibition of breast cancer cell growthin vitro by a tyrosine kinase inhibitor. Cancer Res 52: 3636–3641, 1992

    Google Scholar 

  58. Powers RF, Mani SK, Codina J, Conneely OM, O'Malley BW: Dopaminergic and ligand-indepenedent activation of steroid hormone receptors. Science 254: 1636–1641, 1991

    Google Scholar 

  59. Cormier EM, Jordan VC: Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factor. Eur J Cancer Clin Oncol 25: 57–63, 1989

    Google Scholar 

  60. Stewart AJ, Johnson MD, May FEB, Westley BR: Role of insulin-like growth factors and the type-I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer. J Biol Chem 265: 21172–21178, 1990

    Google Scholar 

  61. Stewart AJ, Westley BR, May FEB: Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br J Cancer 66: 640–648, 1992

    Google Scholar 

  62. Lippman ME: The development of biological therapies for breast cancer. Science 259: 631–632, 1993

    Google Scholar 

  63. Tabibzadeh S: Human endometrium: active site of cytokine production and action. Endocrin Rev 12: 272–290, 1991

    Google Scholar 

  64. DiAugustine RP, Petrusz P, Bell GI, Brown CF, Korach KS, McLachlan JA, Teng CT: Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid. Endocrinology 122: 2355–2363, 1988

    Google Scholar 

  65. Murphy LJ, Murphy LC, Friesen HG: Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol Endocrinol 1: 445–450, 1987

    Google Scholar 

  66. Ghahary A, Murphy LJ: Regulation of uterine insulin-like growth factor receptors by estrogen and variation throughout the estrous cycle. Endocrinology 125: 597–604, 1989

    Google Scholar 

  67. Gardner RM, Verner G, Kirkland JL, Stancel GM: Regulation of uterine epidermal growth factor receptor by estrogen in mature rat and during the estrous cycle. J Steroid Biochem Mol Biol 32: 339–343, 1989

    Google Scholar 

  68. Molnar P, Murphy LJ: Effects of estrogen on uterine IGFBP expression and regulation throughout the estrous cycle. Proc 75th Ann Meet Endocr Soc, Las Vegas 870: 268, 1993

    Google Scholar 

  69. Waites GT, James RFL, Bell SC: Immunohistological localization of human endometrial secretory protein pregnancy associated endometrial α1-globulin, an insulin-like growth factor binding protein, during the menstrual cycle. J Clin Endocrinol Metab 67: 1100–1104, 1988

    Google Scholar 

  70. Murphy LJ, Gong Y, Murphy LC, Bhavnani B: Growth factors in normal and malignant uterine tissue. Ann NY Acad Sci 622: 383–391, 1991

    Google Scholar 

  71. Tamada H, McMaster MT, Flanders KC, Andrew GK, Dey SK: Cell type-specific expression of transforming growth factor-β1 in the mouse uterus during the periimplantation period. Mol Endocrinol 4: 965–972, 1990

    Google Scholar 

  72. Wordinger RJ, Moss AE, Lockard T, Gray D, Chang IF, Jackson TL: Immunohistochemical localization of basic fibroblast growth factor within the mouse uterus. J Reprod Fertil 96: 141–152, 1992

    Google Scholar 

  73. Boehm KD, Daimon M, Gorodeski IG, Sheean LA, Utian WH, Ilan J: Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Mol Reprod Dev 27: 93–101, 1990

    Google Scholar 

  74. Pollard JW, Bartocci A, Arceci RJ, Orlofsky A, Ladner MB, Stanley ER: Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 330: 484–486, 1987

    Google Scholar 

  75. Guilbert L, Robertson SA, Wegmann TG: The trophoblast as an integral component of a macrophage-cytokine network. Immunol Cell Biol 71: 49–57, 1993

    Google Scholar 

  76. Tabibzadeh SS, Santhanam U, Sehgal PB, May LT: Cytokine-induced production of IFN-β2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17β. J Immunol 142: 3134–139, 1989

    Google Scholar 

  77. Pollard JW, Hunt JS, Wiktor-Jedrzejczak W, Stanley ER: A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Develop Biol 148: 273–283, 1991

    Google Scholar 

  78. Rodriguez-Martinez H, Persson E, Hurst M, Stanchev P: Immunohistochemical localization of platelet-derived growth factor receptors in the porcine uterus during the oestrous cycle and pregnancy. Zentralbl Veterinarmed A 39: 1–10, 1992

    Google Scholar 

  79. Tabibzadeh SS, Santhanam U, Sehgal PB, May LT: Cytokine-induced production of IFN-beta 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 beta. J Immunol 142: 3134–3139, 1989

    Google Scholar 

  80. Gurpide E: Endometrial cancer: biochemical and clinical correlates. J Natl Cancer Inst 83: 405–416, 1991

    Google Scholar 

  81. Holinka CF, Hata H, Gravanis A, Kuromoto H, Gurpide E: Effects of estradiol on proliferation of endometrial adenocarcinoma cells (Ishikawa line). J Steroid Biochem 25: 781–786, 1986

    Google Scholar 

  82. Fornander T, Cedermark B, Mattsson A, Skoog L, Theve T, Askergren J, Rutqvist L, Glas U, Silfverswärd C, Somell A, Wilking N, Hjalmar M-L: Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet i: 117–120, 1989

    Google Scholar 

  83. Murphy LJ, Gong Y, Murphy LC: Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol 41: 309–314, 1992

    Google Scholar 

  84. Reynolds RK, Talavera F, Roberts JA, Hopkins MP, Menon KMJ: Regulation of epidermal growth factor and insulinlike growth factor I receptors by estradiol and progesterone in normal and neoplastic endometrial cell cultures. Gynecol Oncol 38: 396–406, 1990

    Google Scholar 

  85. Freiss G. Rochefort H, Vignon F: Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity. Biochem Biophys Res Commun 173: 919–926, 1990

    Google Scholar 

  86. Croxtall JD, Pollard JW, Carey F, Forder RA, White JO: Colony stimulating factor-1 stimulates Ishikawa cell proliferation and lipocortin II synthesis. J Steroid Biochem Mol Biol 42: 121–129, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept of Biochemistry and Molecular Biology, University of Manitoba, R3E OW3, Winnipeg, Manitoba, Canada

    Leigh C. Murphy

Authors
  1. Leigh C. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murphy, L.C. Antiestrogen action and growth factor regulation. Breast Cancer Res Tr 31, 61–71 (1994). https://doi.org/10.1007/BF00689677

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00689677

Key words

Search

Navigation